These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1517052)

  • 21. Cryptogenic fibrosing alveolitis and the fibrosing alveolitis of systemic sclerosis: morphological differences on computed tomographic scans.
    Chan TY; Hansell DM; Rubens MB; du Bois RM; Wells AU
    Thorax; 1997 Mar; 52(3):265-70. PubMed ID: 9093344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accuracy of the typical computed tomographic appearances of fibrosing alveolitis.
    Tung KT; Wells AU; Rubens MB; Kirk JM; du Bois RM; Hansell DM
    Thorax; 1993 Apr; 48(4):334-8. PubMed ID: 8135910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different cytokine profiles in cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a quantitative study of open lung biopsies.
    Majumdar S; Li D; Ansari T; Pantelidis P; Black CM; Gizycki M; du Bois RM; Jeffery PK
    Eur Respir J; 1999 Aug; 14(2):251-7. PubMed ID: 10515397
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study.
    Hubbard R; Venn A; Lewis S; Britton J
    Am J Respir Crit Care Med; 2000 Jan; 161(1):5-8. PubMed ID: 10619790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulmonary sarcoidosis mimicking cryptogenic fibrosing alveolitis on CT.
    Padley SP; Padhani AR; Nicholson A; Hansell DM
    Clin Radiol; 1996 Nov; 51(11):807-10. PubMed ID: 8937326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exposure to commonly prescribed drugs and the etiology of cryptogenic fibrosing alveolitis: a case-control study.
    Hubbard R; Venn A; Smith C; Cooper M; Johnston I; Britton J
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):743-7. PubMed ID: 9517585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrosing alveolitis. Causes, characteristics, and consequences.
    Lillington GA; Siefkin AM
    Postgrad Med; 1982 Apr; 71(4):128-37. PubMed ID: 7071025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prognosis of cryptogenic fibrosing alveolitis.
    Stack BH; Choo-Kang YF; Heard BE
    Thorax; 1972 Sep; 27(5):535-42. PubMed ID: 4538877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic studies in familial fibrosing alveolitis. Possible linkage with immunoglobulin allotypes (Gm).
    Musk AW; Zilko PJ; Manners P; Kay PH; Kamboh MI
    Chest; 1986 Feb; 89(2):206-10. PubMed ID: 3484694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating antibodies to lung protein(s) in patients with cryptogenic fibrosing alveolitis.
    Wallace WA; Roberts SN; Caldwell H; Thornton E; Greening AP; Lamb D; Howie SE
    Thorax; 1994 Mar; 49(3):218-24. PubMed ID: 8202877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cryptogenic fibrosing alveolitis and lung cancer.
    Turner-Warwick M; Lebowitz M; Burrows B; Johnson A
    Thorax; 1980 Jul; 35(7):496-9. PubMed ID: 7434310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cryptogenic fibrosing alveolitis. A study of an indigenous African population.
    Smith C; Feldman C; Levy H; Kallenbach JM; Zwi S
    Respiration; 1990; 57(6):364-71. PubMed ID: 2099570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rising mortality from cryptogenic fibrosing alveolitis.
    Johnston I; Britton J; Kinnear W; Logan R
    BMJ; 1990 Nov; 301(6759):1017-21. PubMed ID: 2249048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aerosolised ribavirin in patients with advanced cryptogenic fibrosing alveolitis: a pilot study.
    Agustí C; Xaubet A; Ballester E; Alarcón A; Picado C
    Thorax; 1993 Jan; 48(1):68-9. PubMed ID: 8434357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mediastinal lymphadenopathy in cryptogenic fibrosing alveolitis: the effect of steroid therapy on the prevalence of nodal enlargement.
    Franquet T; Gimenez A; Alegret X; Rodriguez-Arias JM
    Clin Radiol; 1998 Jun; 53(6):435-8. PubMed ID: 9651059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypertrophic pulmonary osteoarthropathy in four patients with interstitial pulmonary disease.
    Galko B; Grossman RF; Day A; Tenenbaum J; Kirsh J; Rebuck AS
    Chest; 1985 Jul; 88(1):94-7. PubMed ID: 4006563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Occupational dust exposure and the aetiology of cryptogenic fibrosing alveolitis.
    Hubbard R
    Eur Respir J Suppl; 2001 Sep; 32():119s-121s. PubMed ID: 11816818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Desquamative interstitial pneumonia in children. Report of two cases.
    Rosenow EC; O'Connell EC; Harrison EG
    Am J Dis Child; 1970 Oct; 120(4):344-8. PubMed ID: 5493833
    [No Abstract]   [Full Text] [Related]  

  • 39. Idiopathic pulmonary fibrosis/cryptogenic fibrosing alveolitis.
    Fellrath JM; du Bois RM
    Clin Exp Med; 2003 Sep; 3(2):65-83. PubMed ID: 14598183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cryptogenic fibrosing alveolitis.
    Dill J; Ghose T; Landrigan P; MacKeen AD; Macneil AR
    Chest; 1975 Apr; 67(4):411-6. PubMed ID: 1091417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.